natgillin/translations-raw huggingface dataset:
portable fire extinguishers in large aeroplanes for which the first individual certificate of airworthiness is issued on or after 18 May 2019.’;
prenosivim aparatima za gašenje požara u velikim zrakoplovima za koje je prva pojedina svjedodžba o plovidbenosti izdana najranije 18. svibnja 2019.”;
the following Subpart C is added:
dodaje se sljedeći poddio C:
‘SUBPART C — LARGE HELICOPTERS
„PODDIO C – VELIKI HELIKOPTERI
Operators of large helicopters shall ensure that the following extinguishers do not use halon as an extinguishing agent:
Operateri velikih helikoptera osiguravaju da se u sljedećim aparatima kao sredstvo za gašenje požara ne koristi halon:
built-in fire extinguishers for each lavatory waste receptacle for towels, paper or waste in large helicopters for which the individual certificate of airworthiness is first issued on or after 18 February 2020;
ugrađenim aparatima za gašenje pri mjestu za bacanje maramica, papira ili otpada u svakom sanitarnom čvoru u velikim helikopterima za koje je pojedina svjedodžba o plovidbenosti prvi put izdana najranije 18. veljače 2020.;
portable fire extinguishers in large helicopters for which the individual certificate of airworthiness is first issued on or after 18 May 2019.’
prenosivim aparatima za gašenje požara u velikim helikopterima za koje je pojedina svjedodžba o plovidbenosti prvi put izdana najranije 18. svibnja 2019.”.
They were transposed in the Agency's certification specifications for large aeroplanes (CS-25), but they apply only to large aeroplanes of which the certification of the design has been applied for after 1989.
Preneseni su u certifikacijske specifikacije Agencije za velike zrakoplove (CS-25), ali primjenjuju se samo na velike zrakoplove za koje je zahtjev za certificiranje projekta podnesen nakon 1989.
Considering that certain large aeroplanes might not comply with those standards, additional airworthiness specifications should be therefore introduced.
Budući da određeni veliki zrakoplovi možda neće udovoljavati tim standardima, trebalo bi uvesti dodatne specifikacije u pogledu plovidbenosti.
Those new flammability standards apply only to large aeroplanes of which the certification of the design has been applied for after 2009.
Ti novi standardi o gorivosti primjenjuju se samo na velike zrakoplove za koje je zahtjev za certificiranje projekta podnesen nakon 2009.
Considering that certain large aeroplanes might not comply with those standards, additional airworthiness specifications should be introduced.
Budući da određeni veliki zrakoplovi možda neće udovoljavati tim standardima, trebalo bi uvesti dodatne specifikacije u pogledu plovidbenosti.
Third, to gradually mitigate the environmental impact of halon used in the firefighting equipment, the International Civil Aviation Organization (ICAO) has issued new standards by amending ICAO Annex 6 applicable as from 15 December 2011.
Treće, kako bi se postupno umanjio učinak koji na okoliš ima halon koji se nalazi u protupožarnoj opremi, Međunarodna organizacija civilnog zrakoplovstva (ICAO) izdala je nove standarde tako što je izmijenila Prilog 6. ICAO-a, što se primjenjuje od 15. prosinca 2011.
In order to comply with those standards, additional airworthiness specifications should be introduced to newly produced large aeroplanes and large helicopters the design of which has already been certified by the Agency on the basis of certification specifications which allowed the use of halon as a suitable agent.
Kako bi se ti standardi poštovali, dodatne specifikacije u pogledu plovidbenosti trebale bi se uvesti za novoproizvedene velike zrakoplove i velike helikoptere čiji je projekt Agencija već certificirala na temelju certifikacijskih specifikacija kojima je dopuštena uporaba halona kao odgovarajućeg agensa.
Commission Implementing Regulation (EU) 2019/138
Provedbena uredba Komisije (EU) 2019/138
amending Regulations (EC) No 1356/2004, (EC) No 1464/2004, (EC) No 786/2007, (EC) No 971/2008, (EU) No 1118/2010, (EU) No 169/2011 and Implementing Regulations (EU) No 888/2011 and (EU) No 667/2013 as regards the name of the holder of the authorisation for feed additives
o izmjeni uredaba (EZ) br. 1356/2004, (EZ) br. 1464/2004, (EZ) br. 786/2007, (EZ) br. 971/2008, (EU) br. 1118/2010, (EU) br. 169/2011 i provedbenih uredaba (EU) br. 888/2011 i (EU) br. 667/2013 u pogledu naziva nositelja odobrenja za dodatke hrani za životinje
Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition and in particular Article 13(3) thereof,
uzimajući u obzir Uredbu (EZ) br. 1831/2003 Europskog parlamenta i Vijeća od 22. rujna 2003. o dodacima hrani za životinje, a posebno njezin članak 13. stavak 3.,
In accordance with Council Directive 70/524/EEC monensin sodium and narasin, were authorised as feed additives by, respectively, Commission Regulations (EC) No 1356/2004 and (EC) No 1464/2004.
U skladu s Direktivom Vijeća 70/524/EEZ monenzin natrij i narazin odobreni su kao dodaci hrani za životinje uredbama Komisije (EZ) br. 1356/2004 i (EZ) br. 1464/2004.
In accordance with Regulation (EC) No 1831/2003, endo-1,4-beta-mannanase and diclazuril were authorised as feed additives by, respectively, Commission Regulations (EC) No 786/2007, (EC) No 971/2008, (EU) No 1118/2010, (EU) No 169/2011 and Commission Implementing Regulations (EU) No 888/2011 and (EU) No 667/2013.
U skladu s Uredbom (EZ) br. 1831/2003 Europskog parlamenta i Vijeća endo-1,4-beta-mananaza i diklazuril odobreni su kao dodaci hrani za životinje uredbama Komisije (EZ) br. 786/2007, (EZ) br. 971/2008, (EU) br. 1118/2010, (EU) br. 169/2011 i provedbenim uredbama Komisije (EU) br. 888/2011 i (EU) br. 667/2013.
The holder of authorisation, Eli Lilly and Company Ltd, has submitted an application in accordance with Article 13(3) of Regulation (EC) No 1831/2003 proposing to change the name of the holder of the authorisation for the feed additives concerned.
Nositelj odobrenja Eli Lilly and Company Ltd. podnio je zahtjev u skladu s člankom 13. stavkom 3. Uredbe (EZ) br. 1831/2003 u kojem predlaže promjenu naziva nositelja odobrenja za predmetne dodatke hrani za životinje.
The proposed change of the terms of the authorisation is purely administrative in nature and does not entail a fresh assessment of the additives concerned.
Predložena izmjena uvjeta odobrenja u potpunosti je administrativne prirode i nije potrebna nova procjena dotičnog dodatka.
To allow Elanco GmbH to exploit its marketing rights it is necessary to change the terms of the authorisations concerned.
Kako bi se društvu Elanco GmbH omogućilo da iskoristi svoje pravo stavljanja na tržište, potrebno je izmijeniti uvjete predmetnih odobrenja.
Regulations (EC) No 1356/2004, (EC) No 1464/2004, (EC) No 786/2007, (EC) No 971/2008, (EU) No 1118/2010, (EU) No 169/2011 and Implementing Regulations (EU) No 888/2011 and (EU) No 667/2013, should, therefore, be amended accordingly.
Uredbe (EZ) br. 1356/2004, (EZ) br. 1464/2004, (EZ) br. 786/2007, (EZ) br. 971/2008, (EU) br. 1118/2010, (EU) br. 169/2011 i provedbene uredbe (EU) br. 888/2011 i (EU) br. 667/2013 trebalo bi stoga na odgovarajući način izmijeniti.
Since safety reasons do not require the immediate application of the amendments made by this Regulation, it is appropriate to allow a transitional period during which existing stocks may be used up.
Budući da ne postoje sigurnosni razlozi zbog kojih bi bilo potrebno odmah primjenjivati izmjene predviđene ovom Uredbom, primjereno je omogućiti prijelazno razdoblje tijekom kojeg se mogu potrošiti postojeće zalihe.
Amendment to Regulation (EC) No 1356/2004
Izmjena Uredbe (EZ) br. 1356/2004
In the second column of the Annex to Regulation (EC) No 1356/2004, the words ‘Eli Lilly and Company Limited’ are replaced by the words ‘Elanco GmbH’.
U drugom stupcu Priloga Uredbi (EZ) br. 1356/2004 riječi „Eli Lilly and Company Limited” zamjenjuju se riječima „Elanco GmbH”.
Amendment to Regulation (EC) No 1464/2004
Izmjena Uredbe (EZ) br. 1464/2004
In the second column of the Annex to Regulation (EC) No 1464/2004, the words ‘Eli Lilly and Company Limited’ are replaced by the words ‘Elanco GmbH’.
U drugom stupcu Priloga Uredbi (EZ) br. 1464/2004 riječi „Eli Lilly and Company Limited” zamjenjuju se riječima „Elanco GmbH”.
Amendment to Regulation (EC) No 786/2007
Izmjena Uredbe (EZ) br. 786/2007
In the second column of the Annex to Regulation (EC) No 786/2007, the words ‘Eli Lilly and Company Ltd’ are replaced by the words ‘Elanco GmbH’.
U drugom stupcu Priloga Uredbi (EZ) br. 786/2007 riječi „Eli Lilly and Company Ltd” zamjenjuju se riječima „Elanco GmbH”.
Amendment to Regulation (EC) No 971/2008
Izmjena Uredbe (EZ) br. 971/2008
In the second column of the Annex to Regulation (EC) No 971/2008, the words ‘Eli Lilly and Company Ltd’ are replaced by the words ‘Elanco GmbH’.
U drugom stupcu Priloga Uredbi (EZ) br. 971/2008 riječi „Eli Lilly and Company Ltd” zamjenjuju se riječima „Elanco GmbH”.
Amendment to Regulation (EU) No 1118/2010
Izmjena Uredbe (EU) br. 1118/2010
In the second column of the Annex to Regulation (EU) No 1118/2010, the words ‘Eli Lilly and Company Ltd’ are replaced by the words ‘Elanco GmbH’.
U drugom stupcu Priloga Uredbi (EU) br. 1118/2010 riječi „Eli Lilly and Company Ltd” zamjenjuju se riječima „Elanco GmbH”.
Amendment to Regulation (EU) No 169/2011
Izmjena Uredbe (EU) br. 169/2011
In the second column of the Annex to Regulation (EU) No 169/2011, the words ‘Eli Lilly and Company Ltd’ are replaced by the words ‘Elanco GmbH’.
U drugom stupcu Priloga Uredbi (EU) br. 169/2011 riječi „Eli Lilly and Company Ltd” zamjenjuju se riječima „Elanco GmbH”.
Amendment to Regulation (EU) No 888/2011
Izmjena Uredbe (EU) br. 888/2011
In the second column of the Annex to Regulation (EU) No 888/2011 the words ‘Eli Lilly and Company Ltd’ are replaced by the words ‘Elanco GmbH’.
U drugom stupcu Priloga Uredbi (EU) br. 888/2011 riječi „Eli Lilly and Company Ltd” zamjenjuju se riječima „Elanco GmbH”.
Amendment to Regulation (EU) No 667/2013
Izmjena Uredbe (EU) br. 667/2013
Regulation (EU) No 667/2013 is amended as follows:
Uredba (EU) br. 667/2013 mijenja se kako slijedi:
In the title, the words ‘Eli Lilly and Company Ltd’ are replaced by the words ‘Elanco GmbH’;
U naslovu riječi „Eli Lilly and Company Ltd” zamjenjuju se riječima „Elanco GmbH”.
In the second column of the Annex, the words ‘Eli Lilly and Company Ltd’ are replaced by the words ‘Elanco GmbH’.
U drugom stupcu Priloga riječi „Eli Lilly and Company Ltd” zamjenjuju se riječima „Elanco GmbH”.
Transitional measure
Prijelazna mjera
Monensin sodium, narasin, endo-1,4-beta-mannanase, and diclazuril produced and labelled before the date of entry into force of this Regulation in accordance with the rules applicable before that date may continue to be placed on the market and used until stocks are exhausted.
Monenzin natrij, narazin, endo-1,4-beta-mananaza i diklazuril proizvedeni i označeni prije datuma stupanja na snagu ove Uredbe u skladu s pravilima primjenjivima prije tog datuma mogu se i dalje stavljati na tržište i upotrebljavati do isteka zaliha.
Council Directive of 23 November 1970 concerning additives in feeding-stuffs (OJ L 270, 14.12.1970, p. 1).
Direktiva Vijeća od 23. studenoga 1970. o dodacima hrani za životinje (SL L 270, 14.12.1970., str. 1.).
Commission Regulation (EC) No 1356/2004 of 26 July 2004 concerning the authorisation for 10 years of the additive ‘Elancoban’ in feedingstuffs, belonging to the group of coccidiostats and other medicinal substances ( OJ L 251, 27.7.2004, p. 6).
Uredba Komisije (EZ) br. 1356/2004 od 26. srpnja 2004. o odobravanju na 10 godina dodatka hrani za životinje Elancoban, koji pripada skupini Kokcidiostatici i druge ljekovite tvari (SL L 251, 27.7.2004., str. 6).
Commission Regulation (EC) No 1464/2004 of 17 August 2004 concerning the authorisation for 10 years of the additive ‘Monteban’ in feedingstuffs, belonging to the group of coccidiostats and other medicinal substances ( OJ L 270, 18.8.2004, p. 8).
Uredba Komisije (EZ) br. 1464/2004 od 17. kolovoza 2004. o odobravanju na 10 godina dodatka hrani za životinje Monteban, koji pripada skupini Kokcidiostatici i druge ljekovite tvari (SL L 270, 18.8.2004., str. 8).
Commission Regulation (EC) No 786/2007 of 4 July 2007 concerning the authorisation of endo-1,4-beta-mannanase EC 3.2.1.78 (Hemicell) as a feed additive (OJ L 175, 5.7.2007, p. 8).
Uredba Komisije (EZ) br. 786/2007 od 4. srpnja 2007. o odobravanju endo-1,4-beta-mananaze EC 3.2.1.78 (Hemicell) kao dodatka hrani za životinje (SL L 175, 5.7.2007., str. 8.).
Commission Regulation (EC) No 971/2008 of 3 October 2008 concerning a new use of a coccidiostat as additive in feedingstuffs (OJ L 265, 4.10.2008, p. 3).
Uredba Komisije (EZ) br. 971/2008 od 3. listopada 2008. o novom korištenju kokcidiostatika kao dodatka hrani za životinje (SL L 265, 4.10.2008., str. 3.).
Commission Regulation (EU) No 1118/2010 of 2 December 2010 concerning the authorisation of diclazuril as a feed additive for chickens for fattening (holder of authorisation Janssen Pharmaceutica NV) and amending Regulation (EC) No 2430/1999 (OJ L 317, 3.12.2010, p. 5).
Uredba Komisije (EU) br. 1118/2010 od 2. prosinca 2010. o odobrenju diklazurila kao dodatka hrani za životinje za tovne piliće (nositelj odobrenja Janssen Pharmaceutica NV) i izmjeni Uredbe (EZ) br. 2430/1999 (SL L 317, 3.12.2010., str. 5.).
Commission Regulation (EU) No 169/2011 of 23 February 2011 concerning the authorisation of diclazuril as a feed additive for guinea fowls (holder of authorisation Janssen Pharmaceutica N.V.) (OJ L 49, 24.2.2011, p. 6).
Uredba Komisije (EU) br. 169/2011 od 23. veljače 2011. o odobrenju diklazurila kao dodatka hrani za životinje za biserke (nositelj odobrenja Janssen Pharmaceutics N.V.) (SL L 49, 24.2.2011., str. 6.).
Commission Implementing Regulation (EU) No 888/2011 of 5 September 2011 concerning the authorisation of diclazuril as a feed additive for turkeys for fattening (holder of authorisation Janssen Pharmaceutica N.V..) and amending Regulation (EC) No 2430/1999 (OJ L 229, 6.9.2011, p. 9).
Provedbena uredba Komisije (EU) br. 888/2011 od 5. rujna 2011. o odobrenju diklazurila kao dodatka hrani za životinje za purane za tov (nositelj odobrenja Janssen Pharmaceutica N.V.) i izmjeni Uredbe (EZ) br. 2430/1999 (SL L 229, 6.9.2011., str. 9.).
Commission Implementing Regulation (EU) No 667/2013 of 12 July 2013 concerning the authorisation of diclazuril as a feed additive for chickens reared for laying (holder of authorisation Eli Lilly and Company Ltd) and repealing Regulation (EC) No 162/2003 (OJ L 192, 13.7.2013, p. 35).
Provedbena uredba Komisije (EU) br. 667/2013 оd 12. srpnja 2013. o odobrenju diklazurila kao dodatka hrani za kokoši nesilice (nositelj odobrenja Eli Lilly and Company Ltd.) i o stavljanju izvan snage Uredbe (EZ) br. 162/2003 (SL L 192, 13.7.2013., str. 35.).
The holder of authorisation claims that, with effect from 30 March 2018, Elanco GmbH, a division of Eli Lilly and Company Ltd owns the marketing rights for the additives concerned.
Nositelj odobrenja tvrdi da je, s učinkom od 30. ožujka 2018., Elanco GmbH, dio društva Eli Lilly and Company Ltd., vlasnik prava stavljanja na tržište za predmetne dodatke.
The holder of authorisation has submitted relevant data supporting its request.
Nositelj odobrenja dostavio je relevantne podatke kojima podupire svoj zahtjev.
Commission Implementing Regulation (EU) 2019/139
Provedbena uredba Komisije (EU) 2019/139
approving the active substance Beauveria bassiana strain IMI389521, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobravanju aktivne tvari Beauveria bassiana soj IMI389521 u skladu s Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća o stavljanju na tržište sredstava za zaštitu bilja te o izmjeni Priloga Provedbenoj uredbi Komisije (EU) br. 540/2011
In accordance with Article 7(1) of Regulation (EC) No 1107/2009 the Netherlands received on 28 October 2014 an application from Exosect Limited for the approval of the active substance Beauveria bassiana strain IMI389521.
U skladu s člankom 7. stavkom 1. Uredbe (EZ) br. 1107/2009 Nizozemska je 28. listopada 2014. od subjekta Exosect Limited primila zahtjev za odobrenje aktivne tvari Beauveria bassiana soj IMI389521.
In accordance with Article 9(3) of Regulation (EC) No 1107/2009, the Netherlands, as rapporteur Member State, notified the applicant, the other Member States, the Commission and the European Food Safety Authority (‘the Authority’) on 2 June 2015 of the admissibility of the application.
U skladu s člankom 9. stavkom 3. Uredbe (EZ) br. 1107/2009 Nizozemska je kao država članica izvjestiteljica 2. lipnja 2015. obavijestila podnositelja zahtjeva, ostale države članice, Komisiju i Europsku agenciju za sigurnost hrane („Agencija”) o prihvatljivosti zahtjeva.
On 22 February 2016 the rapporteur Member State submitted a draft assessment report to the Commission with a copy to the Authority, assessing whether that active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Država članica izvjestiteljica 22. veljače 2016. Komisiji je dostavila nacrt izvješća o ocjeni, uz kopiju Agenciji, u kojem je ocijenila može li se očekivati da ta aktivna tvar ispunjava mjerila za odobravanje predviđena u članku 4. Uredbe (EZ) br. 1107/2009.
The assessment of the additional information by the rapporteur Member State was submitted to the Authority in the format of an updated draft assessment report on 2 February 2017.
Država članica izvjestiteljica dostavila je Agenciji ocjenu dodatnih informacija 2. veljače 2017. u obliku ažuriranog nacrta izvješća o ocjeni.
On 26 April 2017 the Authority communicated to the applicant, the Member States and the Commission its conclusion on whether the active substance Beauveria bassiana strain IMI389521 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Agencija je 26. travnja 2017. podnositelju zahtjeva, državama članicama i Komisiji dostavila zaključak o tome može li se očekivati da aktivna tvar Beauveria bassiana soj IMI389521 ispunjava mjerila za odobravanje predviđena u članku 4. Uredbe (EZ) br. 1107/2009.
On 24 October 2018 the Commission presented to the Standing Committee on Plants, Animals, Food and Feed the draft review report for Beauveria bassiana strain IMI389521 and a draft Regulation providing that Beauveria bassiana strain IMI389521 is approved.
Komisija je 24. listopada 2018. Stalnom odboru za bilje, životinje, hranu i hranu za životinje dostavila nacrt izvješća o pregledu za tvar Beauveria bassiana soj IMI389521 i nacrt uredbe kojom se predviđa odobrenje tvari Beauveria bassiana soj IMI389521.
It is therefore appropriate to approve Beauveria bassiana strain IMI389521.
Stoga je primjereno odobriti tvar Beauveria bassiana soj IMI389521.
In particular, it is appropriate to include risk mitigation measures where appropriate.
Konkretno, primjereno je, prema potrebi, uključiti mjere za smanjenje rizika.
The active substance Beauveria bassiana strain IMI389521, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna tvar Beauveria bassiana soj IMI389521, kako je navedena u Prilogu I., odobrava se u skladu s uvjetima utvrđenima u tom prilogu.
EFSA Journal 2017;15(5):4831, 21 pp. doi:10.2903/j.efsa.2017.4831.
EFSA Journal 2017.; 15(5):4831, 21 str. doi:10.2903/j.efsa.2017.4831.
Beauveria bassiana strain IMI389521
Beauveria bassiana soj IMI389521
Accession number in the CABI Genetic Resource Collection: IMI389521
Referentni broj u Zbirci genetskih resursa CABI: IMI389521
Max. level of beauvericin: 0,09 mg/kg
Najveća razina beauvericina: 0,09 mg/kg
19 February 2019
19. veljače 2019.
19 February 2029
19. veljače 2029.
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Beauveria bassiana strain IMI389521, and in particular Appendices I and II thereof, shall be taken into account.
Za provedbu jedinstvenih načela iz članka 29. stavka 6. Uredbe (EZ) br. 1107/2009 moraju se uzeti u obzir zaključci izvješća o pregledu za tvar Beauveria bassiana soj IMI389521, a posebno njegovi dodaci I. i II.
the storage stability of the formulation(s) containing B. bassiana strain IMI389521 including the level of the metabolite beauvericin content after storage,
stabilnost kod skladištenja pripravka (ili više njih) koji sadržava tvar B. bassiana soj IMI389521, uključujući udio metabolita beauvericina nakon skladištenja,
the content of the metabolite beauvericin produced under the application conditions,
sadržaj metabolita beauvericina proizvedenog u određenim uvjetima primjene,
the risk posed by beauvericin in infected insects present in the stored grain.
rizik koji predstavlja beauvericin u zaraženim insektima prisutnima u skladištenom zrnju.
Measures are required to ensure that such products do not enter the food and feed chain, taking into account the natural background level of beauvericin on cereal grains,
Potrebno je poduzeti mjere kako bi se osiguralo da takvi proizvodi ne uđu u lanac hrane i hrane za životinje, uzimajući u obzir uobičajenu razinu prisutnosti beauvericina na zrnima žitarica,
the protection of operators and workers, taking into account that B. bassiana strain IMI389521 is to be considered, as any micro-organism, as a potential sensitiser.
zaštitu korisnika sredstva i djelatnika, uzimajući u obzir to da se smatra da tvar B. bassiana soj IMI389521, kao i svaki drugi mikroorganizam, može uzrokovati preosjetljivost.
The compliance with strict maintenance of environmental conditions and quality control analysis during the manufacturing process, in order to ensure the fulfilment of the limits on microbiological contamination as referred to in the Working Document SANCO/12116/2012
Strogo održavanje ekoloških uvjeta i analiza kontrole kvalitete tijekom proizvodnog postupka kako bi se osiguralo poštovanje graničnih vrijednosti mikrobiološke kontaminacije iz radnog dokumenta SANCO/12116/2012.
the storage stability of the formulation(s) containing B. bassiana strain IMI389521 including the level of the metabolite beauvericin content after storage;
stabilnost kod skladištenja pripravka (ili više njih) koji sadržava tvar B. bassiana soj IMI389521, uključujući udio metabolita beauvericina nakon skladištenja,
the content of the metabolite beauvericin produced under the application conditions;
sadržaj metabolita beauvericina proizvedenog u određenim uvjetima primjene,
Measures are required to ensure that such products do not enter the food and feed chain, taking into account the natural background level of beauvericin on cereal grains;
Potrebno je poduzeti mjere kako bi se osiguralo da takvi proizvodi ne uđu u lanac hrane i hrane za životinje, uzimajući u obzir uobičajenu razinu prisutnosti beauvericina na zrnima žitarica,
The compliance with strict maintenance of environmental conditions and quality control analysis during the manufacturing process, in order to ensure the fulfilment of the limits on microbiological contamination as referred to in the Working Document SANCO/12116/2012.
Strogo održavanje ekoloških uvjeta i analiza kontrole kvalitete tijekom proizvodnog postupka kako bi se osiguralo poštovanje graničnih vrijednosti mikrobiološke kontaminacije iz radnog dokumenta SANCO/12116/2012.
https://ec.europa.eu/food/sites/food/files/plant/docs/pesticides_ppp_app-proc_guide_phys-chem-ana_microbial-contaminant-limits.pdf’
https://ec.europa.eu/food/sites/food/files/plant/docs/pesticides_ppp_app-proc_guide_phys-chem-ana_microbial-contaminant-limits.pdf.”
Conclusion on the peer review of the pesticide risk assessment of the active substance Beauveria bassiana IMI389521.
Conclusion on the peer review of the pesticide risk assessment of the active substance Beauveria bassiana IMI389521 (Zaključak o stručnom pregledu procjene rizika od uporabe aktivne tvari Beauveria bassiana IMI389521 kao pesticida).
Commission Implementing Regulation (EU) 2019/144
Provedbena uredba Komisije (EU) 2019/144